To Improve Access To Diagnostics, Countries Must Adapt The WHO Essential Diagnostics List - Forbes, February 1, 2021

Published: 1 February 2021

Dr. Madhukar Pai, Professor in the Department of Epidemiology, Biostatistics and Occupational Health, writes in Forbes about the World Health Organization (WHO) third edition of its Model List of Essential In Vitro Diagnostics (EDL) and argues for each country to adopt and adapt the list to suit their priorities and needs.

Read the piece now

Back to top